HPC nộp bản tóm tắt yêu cầu bác bỏ vụ kiện CME chống lại CFTC, viện dẫn nguy cơ đối với sự đổi mới trong giao sau vĩnh viễn của Mỹ

The Huo Xing Cai Jing report states that on September 9, the Hyperliquid Policy Center (HPC) submitted an amicus curiae brief urging the U.S. District Court for the District of Columbia to dismiss the lawsuit filed by CME against the CFTC. The brief was filed by Elizabeth Prelogar, former U.S. Deputy Solicitor General at Cooley LLP. In May of this year, the CFTC approved Kalshi’s listing of Bitcoin perpetual contracts as a futures product on regulated U.S. trading platforms and confirmed that other U.S. derivatives exchanges could also launch similar digital asset contracts. CME subsequently filed a lawsuit seeking to overturn the decision. HPC argues that CME has failed to demonstrate actual harm caused by the CFTC’s decision and therefore lacks standing under Article III of the Constitution; furthermore, the Commodity Exchange Act is designed to promote responsible innovation and fair competition among exchanges, and CME’s attempt to block competitors from launching new products falls outside the scope of legal protection under this statute. HPC notes that the outcome of this case could also impact the entry of perpetual contracts and on-chain markets such as Hyperliquid into the U.S. regulatory framework.